A Review of The Current Chronic Heart Failure Treatment Guidelines
The session will review the pathophysiology and guideline directed medical therapy for chronic heart failure. This includes reviewing the clinical presentation and classifications of chronic heart failure, the difference between HFrEF and HFpEF and a review of pharmacologic and nonpharmacologic treatment options. Additionally, the session will review latest guidelines for treatment management.
Learning Objectives
At the completion of this activity, the participant should be able to:
- Describe the pathogenesis clinical presentation and classifications of chronic heart failure
- Determine the difference between heart failure with reduced ejection fraction and heart failure with preserved ejection fraction
- Outline the 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America Guideline for the Management of Heart Failure and the 2023 ACC Expert Consensus Decision Pathway on the Management of Heart Failure with Preserved Ejection Fraction
- Review the pharmacologic and nonpharmacologic treatment options for chronic heart failure
Presenter
Ashley Smith, PharmD, is a 2023-2024 MCPHS University/Atrius Health PGY-1 pharmacy resident. She earned her Doctor of Pharmacy at St. John Fisher University in Rochester, NY, where she was an active member in organizations such as the American College of Clinical Pharmacy and the American Society of Consultant Pharmacists. Ashley’s professional interests include chronic disease state management specifically in chronic heart failure, hypertension, type 2 diabetes and COPD/Asthma.
Release Date: April 9, 2024
Expiration Date: April 9, 2025
ACPE UAN: 0026-0000-24-009-H01-P | Knowledge
Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1 (0.1 CEU)
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1 contact hours (0.1 CEUs).
In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.
Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.
Ashley Smith, PharmD, has no financial relationships with ineligible companies to disclose.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.
No funding from industry provided for this event. No exhibitors will be present